| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new era for equity in meningococcal disease prevention
|
Wang, Bing
|
|
|
23 |
12 |
p. 1329-1330
|
artikel
|
| 2 |
A pandemic playbook
|
Balakrishnan, Vijay Shankar
|
|
|
23 |
12 |
p. 1340
|
artikel
|
| 3 |
A promising candidate for a universal influenza vaccine
|
Isakova-Sivak, Irina
|
|
|
23 |
12 |
p. 1327-1329
|
artikel
|
| 4 |
Are bivalent vaccines better than ancestral-virus monovalent vaccines in protecting against severe omicron COVID-19?
|
Madhi, Shabir A
|
|
|
23 |
12 |
p. 1325-1327
|
artikel
|
| 5 |
Boost for COVID-19 testing in the USA
|
Bagcchi, Sanjeet
|
|
|
23 |
12 |
p. e514
|
artikel
|
| 6 |
Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews
|
Litvinjenko, Stefan
|
|
|
23 |
12 |
p. 1395-1407
|
artikel
|
| 7 |
Cholera in Sudan
|
Samarasekera, Udani
|
|
|
23 |
12 |
p. e515
|
artikel
|
| 8 |
Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study
|
Ogoina, Dimie
|
|
|
23 |
12 |
p. 1418-1428
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2023; published online Sept 28. https://doi.org/10.1016/S1473-3099(23)00493-0
|
|
|
|
23 |
12 |
p. e511
|
artikel
|
| 10 |
COVID-19 in the USA
|
Bagcchi, Sanjeet
|
|
|
23 |
12 |
p. 1342
|
artikel
|
| 11 |
Coxsackievirus A6 pneumonia in a child
|
Zhou, Jing
|
|
|
23 |
12 |
p. e567
|
artikel
|
| 12 |
Dengue fever: working towards global control considering biological, social, and planetary determinants
|
Bellissimo-Rodrigues, Fernando
|
|
|
23 |
12 |
p. e506
|
artikel
|
| 13 |
Developing a vaccine against Sudan virus disease
|
Manno, Daniela
|
|
|
23 |
12 |
p. 1333-1335
|
artikel
|
| 14 |
Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study
|
Tan, Celine Y
|
|
|
23 |
12 |
p. 1343-1348
|
artikel
|
| 15 |
Frequent screening for asymptomatic chlamydia and gonorrhoea infections in men who have sex with men: time to re-evaluate?
|
Williams, Eloise
|
|
|
23 |
12 |
p. e558-e566
|
artikel
|
| 16 |
Highlights from ASTMH 2023
|
De Ambrogi, Marco
|
|
|
23 |
12 |
p. e513
|
artikel
|
| 17 |
Highlights from IDWeek 2023
|
Downes, Phoebe
|
|
|
23 |
12 |
p. e512
|
artikel
|
| 18 |
Hoosen Jerry Coovadia
|
Manyukwe, Clemence
|
|
|
23 |
12 |
p. 1337
|
artikel
|
| 19 |
Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial
|
Peterson, James
|
|
|
23 |
12 |
p. 1370-1382
|
artikel
|
| 20 |
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial
|
Leroux-Roels, Isabel
|
|
|
23 |
12 |
p. 1360-1369
|
artikel
|
| 21 |
Improving measurement of tuberculosis care cascades to enhance people-centred care
|
Faust, Lena
|
|
|
23 |
12 |
p. e547-e557
|
artikel
|
| 22 |
Infectious diseases surveillance update
|
Islam, Tanzina
|
|
|
23 |
12 |
p. e518
|
artikel
|
| 23 |
Influenza vaccine shake-up
|
The Lancet Infectious Diseases,
|
|
|
23 |
12 |
p. 1323
|
artikel
|
| 24 |
Khitam Muhsen—tackling infection inequalities in Israel
|
Kirby, Tony
|
|
|
23 |
12 |
p. 1339
|
artikel
|
| 25 |
Mpox: interdependence and inequity
|
Nakoune, Emmanuel
|
|
|
23 |
12 |
p. 1335-1336
|
artikel
|
| 26 |
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study
|
Mateo-Urdiales, Alberto
|
|
|
23 |
12 |
p. 1349-1359
|
artikel
|
| 27 |
Research in brief
|
Devi, Sharmila
|
|
|
23 |
12 |
p. e519
|
artikel
|
| 28 |
Robert A Lamb
|
Bagcchi, Sanjeet
|
|
|
23 |
12 |
p. 1338
|
artikel
|
| 29 |
Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial
|
Das, Rituparna
|
|
|
23 |
12 |
p. 1383-1394
|
artikel
|
| 30 |
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial
|
Mwesigwa, Betty
|
|
|
23 |
12 |
p. 1408-1417
|
artikel
|
| 31 |
Simian malaria: a narrative review on emergence, epidemiology and threat to global malaria elimination
|
Fornace, Kimberly M
|
|
|
23 |
12 |
p. e520-e532
|
artikel
|
| 32 |
Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy
|
Abo, Yara-Natalie
|
|
|
23 |
12 |
p. e533-e546
|
artikel
|
| 33 |
Targeting vulnerable populations for tuberculosis: does one size fit all?
|
Martinez, Leonardo
|
|
|
23 |
12 |
p. 1332-1333
|
artikel
|
| 34 |
The quest for a cytomegalovirus vaccine continues
|
Chiuppesi, Flavia
|
|
|
23 |
12 |
p. 1330-1332
|
artikel
|
| 35 |
The superiority of bivalent over monovalent booster vaccines
|
Arbel, Ronen
|
|
|
23 |
12 |
p. 1324-1325
|
artikel
|
| 36 |
The US–Mexico border, migration crisis, and falciparum malaria
|
Rendón-Hernández, Ana Patricia
|
|
|
23 |
12 |
p. e507-e508
|
artikel
|
| 37 |
Tsogolo La Thanzi
|
Sherwood-Martin, Hollie
|
|
|
23 |
12 |
p. 1341
|
artikel
|
| 38 |
UK Covid-19 Inquiry
|
Burki, Talha
|
|
|
23 |
12 |
p. e516-e517
|
artikel
|
| 39 |
Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1
|
Lassaunière, Ria
|
|
|
23 |
12 |
p. e509-e510
|
artikel
|
Tijdschrift beschrijving